ARCTICZYMES TECHNOLOGIES ASA |
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 24.85 NOK | +0.81% |
|
+5.07% | -40.83% |
| May. 13 | ArcticZymes Technologies ASA Announces Board Resignations | CI |
| May. 08 | ArcticZymes Technologies ASA Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Presenter SpeechJethro Holter (Executives)Okay. Welcome to the Q1 presentation. Before we kick...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Arcticzymes Technologies ASA is a Norway-based holding company providing support functions to the ArcticZymes AS subsidiary including distribution, administration, finance, Information Technology (IT) and quality assurance. As a life science company, Arcticzymes Technologies ASA is focused on the development, manufacturing, and commercialization of novel and high-quality recombinant enzymes for use in molecular research, In Vitro Diagnostics (IVD) and biomanufacturing. Some of the key features of the Companyâs enzymes include cold activeness and salt tolerance. The Companyâs divided into two operating segments; Enzymes and Corporate. Arcticzymes established logistic hubs in the United States and the Netherlands to serve its customers more efficiently.
Calendar
2024-06-04
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
24.65
NOK
Average target price
27.5
NOK
Spread / Average Target
+11.56%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -40.83% | 118M | |
| +44.48% | 55.07B | |
| +43.57% | 40.22B | |
| -0.86% | 41.79B | |
| -7.59% | 28.17B | |
| +12.30% | 26.28B | |
| -21.83% | 18.93B | |
| +7.15% | 13.03B | |
| +29.40% | 12.26B | |
| +25.15% | 12.21B |
- Stock Market
- Equities
- AZT Stock
- News ArcticZymes Technologies ASA
- Transcript : Biotec Pharmacon ASA, Q1 2020 Earnings Call, Apr 23, 2020